Inizia
ReutersReuters

Briacell Therapeutics’ Subsidiary, BriaPro, Files Patent Application For Immuno-Oncology Platform With Novel Multitargeting Agents

RefinitivMeno di 1 minuto di lettura
BCT

Briacell Therapeutics Corp BCT:

  • BRIACELL’S SUBSIDIARY, BRIAPRO, FILES PATENT APPLICATION FOR IMMUNO-ONCOLOGY PLATFORM WITH NOVEL MULTITARGETING AGENTS

Azioni CanadaAzioni USAReuters
refinitivrefinitiv
© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html
Accedi o crea un account gratuito per leggere queste notizie

Altre notizie da Reuters